Analyst upgrades and revised price targets are strong indicators that can influence investor sentiment and stock prices. Morgan Stanley's upgrade from Equal-Weight to Overweight suggests a bullish outlook on CRWD, and the substantial increase in the price target from $203 to $304 indicates a strong conviction in the company's growth potential. This news is likely to be taken positively by the market, leading to an increase in investor confidence and potentially driving up the stock price in the short term.